CompletedNot Applicable

Fertility After Intrauterine Tamponing Balloon: Where Are we

France59 participantsStarted 2019-11-19

Plain-language summary

Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms. This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Vaginal birth * Post partum haemorrhage * Intrauterine tamponing balloon * Between 2012 and 2017 * CHRU Lille and CH Valenciennes Exclusion Criteria: * Minor patients * Initial intake started in another center (postpartum transfer). * Refusal to participate in the study * Invasive treatments for postpartum haemorrhage * Caesarean

What they're measuring

Frequency of infertility

Timeframe: 7 years

Trial details

NCT IDNCT04133402

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-27

View on ClinicalTrials.gov More Hemorrhage Postpartum trials